Back to 
Point72 Asset Management, L.P.
Point72 Asset Management, L.P.
PTGXShowing 2 of 18 quarters
Position history for Point72 Asset Management, L.P.'s holdings in PROTAGONIST THERAPEUTICS INC
No. Point72 Asset Management exited its PTGX (Protagonist Therapeutics) position in Q4 2024. Its Q3 2024 13F listed 214,872 shares worth $9.7M. Point72 Asset Management first reported PTGX in Q3 2019 and held it in 15 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$9.7M
Total Shares Change
-214,872
Quarter-by-Quarter History
Other major holders of PTGX: BlackRock, Inc., FARALLON CAPITAL MANAGEMENT, L.L.C.